thrombopoietin 
GtoPdb Ligand ID: 5063
|
Compound class:
Endogenous peptide in human, mouse or rat
Comment: This is the endogenous ligand of the thrombopoietin receptor. It promotes proliferation of megakaryocytic cells, which leads to increased platelet production. Human TPO is not used therapeutically as it is associated with a risk of immunogenicity and the development of neutralizing anti-TPO antibodies [1-2]. As a result of this outcome small molecule TPO receptor agonists have been developed to mimic the platelet-promoting action of native TPO.
Species: Human
View more information in the IUPHAR Pharmacology Education Project: thrombopoietin |
| Natural/Endogenous Targets | ||
|
||
| Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License